Terms: = Thyroid cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
61 results:
1. Methylation-Mediated Silencing of ATF3 Promotes thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
2. Comparison of the Efficiency of Radiofrequency and Microwave Ablation Methods in the treatment of Benign thyroid Nodules.
Cerit MN; Yücel C; Cerit ET; Yalçın MM; Şendur HN; Oktar SÖ
Acad Radiol; 2023 Oct; 30(10):2172-2180. PubMed ID: 37357048
[TBL] [Abstract] [Full Text] [Related]
3. Role of 18 F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus.
Sarswat S; Khan D; Sagar S; Kumar R
Nucl Med Commun; 2023 Aug; 44(8):726-731. PubMed ID: 37272295
[TBL] [Abstract] [Full Text] [Related]
4. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.
Mauguen A; Grewal RK; Augensen F; Abusamra M; Mahajan S; Jayaprakasam VS; Osborne J; Haque S; Wong BZY; Ghossein RA; Fagin J; Schӧder H; Tuttle RM; Ho A; Humm JL; Larson SM
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2971-2983. PubMed ID: 37171634
[TBL] [Abstract] [Full Text] [Related]
5.
Rizzo A; Racca M; Cauda S; Balma M; Dall'Armellina S; Dionisi B; Mossetti C; Bruna MC; Freddi M; Palestini N
Endocrine; 2023 May; 80(2):433-440. PubMed ID: 36495390
[TBL] [Abstract] [Full Text] [Related]
6. Correlation analysis of I-131 SPECT/CT uptake parameters with the success ablation treatment of thyroid remnant in patients with low-intermediate-risk differentiated thyroid cancer.
Zhang Q; Xu W
Nucl Med Commun; 2022 Oct; 43(10):1051-1057. PubMed ID: 35972341
[TBL] [Abstract] [Full Text] [Related]
7. 18F-FDG PET/CT concurrent with first radioiodine post-therapeutic scan in high risk differentiated thyroid cancer: a useful tool or just an expensive diversion?
Rizzo A; Perotti G; Zagaria L; Lanni V; Racca M; Palestini N; Salvatori M
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):158-166. PubMed ID: 35238517
[TBL] [Abstract] [Full Text] [Related]
8. Pre-treatment
Li L; Zheng J; Liu Z; Huang Y; Xiao J; Wang S; Yu Q; Zhang Q; Hu X; Zhao W; Hou W; Spring Kong FM; Yu J; Yuan S
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e238-e245. PubMed ID: 35063328
[TBL] [Abstract] [Full Text] [Related]
9. Application of Pet-CT Fusion Deep Learning Imaging in Precise Radiotherapy of thyroid cancer.
Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
J Healthc Eng; 2021; 2021():2456429. PubMed ID: 34413967
[TBL] [Abstract] [Full Text] [Related]
10. Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia.
Al-Mohammed HI; Sulieman A; Mayhoub FH; Salah H; Lagarde C; Alkhorayef M; Aldhebaib A; Kappas C; Bradley DA
Sci Rep; 2021 Jul; 11(1):14557. PubMed ID: 34267237
[TBL] [Abstract] [Full Text] [Related]
11. Intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer: A dosimetric comparison.
Nguyen ML; Cantrell JN; Ahmad S; Henson C
Med Dosim; 2021 Autumn; 46(3):259-263. PubMed ID: 33648823
[TBL] [Abstract] [Full Text] [Related]
12. The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer.
Konishi K; Ishiba R; Ikenohira T; Asao T; Hirata M; Ohira K; Komatsu T; Sawada M; Tanahashi Y; Goshima S; Magata Y; Nakamura K
Ann Nucl Med; 2021 Feb; 35(2):159-166. PubMed ID: 33387279
[TBL] [Abstract] [Full Text] [Related]
13.
Thakur S; Daley B; Millo C; Cochran C; Jacobson O; Lu H; Wang Z; Kiesewetter D; Chen X; Vasko V; Klubo-Gwiezdzinska J
Clin Cancer Res; 2021 Mar; 27(5):1399-1409. PubMed ID: 33355247
[TBL] [Abstract] [Full Text] [Related]
14. Distinguishing Patients With Distant Metastatic Differentiated thyroid cancer Who Biochemically Benefit From Next Radioiodine treatment.
Sa R; Cheng L; Jin Y; Fu H; Shen Y; Chen L
Front Endocrinol (Lausanne); 2020; 11():587315. PubMed ID: 33304320
[TBL] [Abstract] [Full Text] [Related]
15. U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors.
Papadopoulos KP; Borazanci E; Shaw AT; Katayama R; Shimizu Y; Zhu VW; Sun TY; Wakelee HA; Madison R; Schrock AB; Senaldi G; Nakao N; Hanzawa H; Tachibana M; Isoyama T; Nakamaru K; Deng C; Li M; Fan F; Zhao Q; Gao Y; Seto T; Jänne PA; Ou SI
Clin Cancer Res; 2020 Sep; 26(18):4785-4794. PubMed ID: 32591465
[TBL] [Abstract] [Full Text] [Related]
16. Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma.
Yamazaki H; Sugino K; Matsuzu K; Masaki C; Akaishi J; Hames K; Tomoda C; Suzuki A; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Masuda M; Ito K
Endocrine; 2020 Oct; 70(1):115-122. PubMed ID: 32307657
[TBL] [Abstract] [Full Text] [Related]
17. ABLATION OF CYSTIC thyroid NODULES WITH N-BUTYL CYANOACRYLATE: A PRELIMINARY STUDY.
Yuce G; Ateş OF; Polat B; Genç B; Canyigit M
Endocr Pract; 2020 May; 26(5):492-498. PubMed ID: 31968193
[No Abstract] [Full Text] [Related]
18. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
[TBL] [Abstract] [Full Text] [Related]
19. TSH suppression aggravates arterial inflammation - an
Boswijk E; Sanders KJC; Broeders EPM; de Ligt M; Vijgen GHEJ; Havekes B; Mingels AMA; Wierts R; van Marken Lichtenbelt WD; Schrauwen P; Mottaghy FM; Wildberger JE; Bucerius J
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1428-1438. PubMed ID: 30859432
[TBL] [Abstract] [Full Text] [Related]
20. Quality of Information Available on YouTube Videos Pertaining to thyroid cancer.
Aydin MA; Akyol H
J Cancer Educ; 2020 Jun; 35(3):599-605. PubMed ID: 30838529
[TBL] [Abstract] [Full Text] [Related]
[Next]